News in brief - August 2014

on the 4 August 2014

Other new launches, licence changes and updates relevant to general practice.

Fenistil (penciclovir) is used to treat herpes simplex virus infection of the lips and face in adults and children over 12 years of age. | SCIENCE PHOTO LIBRARY
Fenistil (penciclovir) is used to treat herpes simplex virus infection of the lips and face in adults and children over 12 years of age. | SCIENCE PHOTO LIBRARY
  • Janssen-Cilag has launched Sylvant (siltuximab) for the treatment of multicentric Castleman's disease in adults who are HIV-negative and human herpesvirus-8 negative.
  • The cold sore cream Fenistil (penciclovir) has been reclassified from a P medicine to a GSL.
  • Arzerra (ofatumumab) is now indicated in combination with chlorambucil or bendamustine for the treatment of chronic lymphocytic leukaemia in previously untreated patients ineligible for fludarabine-based therapy.

Follow MIMS on Twitter

Sign up for MIMS bulletins

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

The most up-to-date drug information at your fingertips.

  • Get the prescribing support you need.
  • Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Register Now
Already Registered?

Forgotten password?

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Twitter  

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more